| 2016-10-17 08:06:42|
MSTX, PHG 08:06 10/17 10/17/16
Mast Therapeutics announces supply agreement with Philips
Mast Therapeutics (MSTX) announced that its wholly-owned subsidiary, Aires Pharmaceuticals, has entered into a collaborative agreement with Philips Respironics, the sleep and respiratory care business of Royal Philips (PHG) related to the supply of Philips' I-neb Adaptive Aersol Delivery devices and related consumables for the nebulized delivery of the company's lead product candidate, AIR001, a sodium nitrite solution for intermittent inhalation. The I-neb handheld AAD system is a small, portable and virtually silent vibrating mesh technology nebulizer system designed to deliver more precise, reproducible doses of medication faster than conventional jet or ultrasonic nebulizers.